BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1623 related articles for article (PubMed ID: 30407616)

  • 1. Cannabis for the treatment of Crohn's disease.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012853. PubMed ID: 30407616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cannabis for the treatment of ulcerative colitis.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibiotics for induction and maintenance of remission in Crohn's disease.
    Townsend CM; Parker CE; MacDonald JK; Nguyen TM; Jairath V; Feagan BG; Khanna R
    Cochrane Database Syst Rev; 2019 Feb; 2(2):CD012730. PubMed ID: 30731030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anti-IL-12/23p40 antibodies for maintenance of remission in Crohn's disease.
    Davies SC; Nguyen TM; Parker CE; MacDonald JK; Jairath V; Khanna R
    Cochrane Database Syst Rev; 2019 Dec; 12(12):CD012804. PubMed ID: 31828765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adalimumab for induction of remission in Crohn's disease.
    Abbass M; Cepek J; Parker CE; Nguyen TM; MacDonald JK; Feagan BG; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2019 Nov; 2019(11):. PubMed ID: 31742665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adalimumab for maintenance of remission in Crohn's disease.
    Townsend CM; Nguyen TM; Cepek J; Abbass M; Parker CE; MacDonald JK; Khanna R; Jairath V; Feagan BG
    Cochrane Database Syst Rev; 2020 May; 5(5):CD012877. PubMed ID: 32413933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fecal transplantation for treatment of inflammatory bowel disease.
    Imdad A; Nicholson MR; Tanner-Smith EE; Zackular JP; Gomez-Duarte OG; Beaulieu DB; Acra S
    Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012774. PubMed ID: 30480772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natalizumab for induction of remission in Crohn's disease.
    Nelson SM; Nguyen TM; McDonald JW; MacDonald JK
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD006097. PubMed ID: 30068022
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enteral nutrition for maintenance of remission in Crohn's disease.
    Akobeng AK; Zhang D; Gordon M; MacDonald JK
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD005984. PubMed ID: 30098021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Azathioprine and 6-mercaptopurine for maintenance of surgically-induced remission in Crohn's disease.
    Gordon M; Taylor K; Akobeng AK; Thomas AG
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD010233. PubMed ID: 25081347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low dose naltrexone for induction of remission in Crohn's disease.
    Parker CE; Nguyen TM; Segal D; MacDonald JK; Chande N
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD010410. PubMed ID: 29607497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminosalicylates for induction of remission or response in Crohn's disease.
    Lim WC; Wang Y; MacDonald JK; Hanauer S
    Cochrane Database Syst Rev; 2016 Jul; 7(7):CD008870. PubMed ID: 27372735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low dose naltrexone for induction of remission in Crohn's disease.
    Segal D; Macdonald JK; Chande N
    Cochrane Database Syst Rev; 2014 Feb; (2):CD010410. PubMed ID: 24558033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral Janus kinase inhibitors for maintenance of remission in ulcerative colitis.
    Davies SC; Hussein IM; Nguyen TM; Parker CE; Khanna R; Jairath V
    Cochrane Database Syst Rev; 2020 Jan; 1(1):CD012381. PubMed ID: 31984480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    Khanna R; Preiss JC; MacDonald JK; Timmer A
    Cochrane Database Syst Rev; 2015 May; (5):CD007572. PubMed ID: 25942580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Budesonide for maintenance of remission in Crohn's disease.
    Kuenzig ME; Rezaie A; Seow CH; Otley AR; Steinhart AH; Griffiths AM; Kaplan GG; Benchimol EI
    Cochrane Database Syst Rev; 2014 Aug; 2014(8):CD002913. PubMed ID: 25141071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-IL-12/23p40 antibodies for induction of remission in Crohn's disease.
    MacDonald JK; Nguyen TM; Khanna R; Timmer A
    Cochrane Database Syst Rev; 2016 Nov; 11(11):CD007572. PubMed ID: 27885650
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Withdrawal of immunosuppressant or biologic therapy for patients with quiescent Crohn's disease.
    Boyapati RK; Torres J; Palmela C; Parker CE; Silverberg OM; Upadhyaya SD; Nguyen TM; Colombel JF
    Cochrane Database Syst Rev; 2018 May; 5(5):CD012540. PubMed ID: 29756637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Azathioprine or 6-mercaptopurine for maintenance of remission in Crohn's disease.
    Chande N; Patton PH; Tsoulis DJ; Thomas BS; MacDonald JK
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD000067. PubMed ID: 26517527
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cannabis for the Treatment of Crohn's Disease and Ulcerative Colitis: Evidence From Cochrane Reviews.
    Kafil TS; Nguyen TM; MacDonald JK; Chande N
    Inflamm Bowel Dis; 2020 Mar; 26(4):502-509. PubMed ID: 31613959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 82.